Pipeline Insight: Inflammatory Bowel Disease now available at ReportsandReports
Datamonitor forecasts the inflammatory bowel disease market to become increasingly competitive with the anticipated launch of seven new products, spanning five drug classes from 2010 to 2019.
View full press release